Innovate UK

Esox Biologics provides innovative and sustainable solutions for aquatic veterinary medicine. The company offers a disease prediction platform called eForesee, which uses data-driven predictions unique to individual farms. Regular monitoring of the aquatic environment and livestock health is a key component of their services. Esox Biologics utilizes extensive knowledge of the aquatic microbiome to prevent the spread of infectious diseases among aquatic animals by collecting environmental DNA and employing next-generation sequencing technologies.

Naitive is a population health company focused on transforming patient care through the development of AI-enabled clinical pathways. It specializes in creating medical device technology aimed at preventing chronic diseases. The company's software leverages artificial intelligence, clinical data, and digital interventions to enhance the detection, treatment, and management of chronic conditions. By utilizing scalable computational capabilities, Naitive's solutions enable clinicians to improve care coordination while reducing costs, time, and the likelihood of treatment failures.

Purple Transform is an artificial intelligence company that enhances decision-making accuracy through digital intelligence. It offers a range of business intelligence software services, including trespasser detection, crowding analysis, vehicle analysis, IoT insights, and financial insights, to help organizations create safer and more secure workplaces.

Bendi is a data analytics company that specializes in enhancing global supply chain tracking and risk management. Its platform provides real-time traceability and risk monitoring, significantly reducing potential human rights, environmental, and governance risks associated with supply chains. By mapping millions of data points from diverse sources such as news articles, legal cases, and social media across multiple languages, Bendi equips businesses in various sectors—including fashion, textiles, retail, and advanced manufacturing—with actionable insights. This allows companies to streamline their operations, conduct audits more efficiently, and gain a comprehensive understanding of their supply chains.

AgriSound is an agri-tech company that specializes in advanced sound analysis to monitor insect activity, particularly focusing on pollinators. The company has developed a pollination management platform that utilizes sound, environmental, and visual technology sensors to record and analyze insect behavior in near real-time. This innovative approach allows beekeepers, farmers, and researchers to remotely manage beehives and gain insights into hive status and pollination dynamics. By employing predictive algorithms, AgriSound's platform helps identify subtle changes that may impact pollination, enabling users to make informed decisions and take appropriate actions to maintain optimal pollination conditions. Ultimately, AgriSound aims to enhance agricultural operations while promoting biodiversity.

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

SökerData is a biotechnology company that specializes in research and data analysis solutions focused on disease-related datasets. The company has developed a data visualization platform designed to analyze biomarkers in clinical outcomes across various demographics. This platform provides researchers with essential features and tools for interpreting large datasets, facilitating early drug discovery. By enabling researchers to better understand the impact of biomarkers on different populations, SökerData supports informed decision-making and enhances the comprehension of disease outcomes in diverse demographic groups.

AMPLY Discovery is a biotechnology company focused on drug discovery, utilizing machine learning and synthetic biology to explore vast biological datasets for novel drug and nutraceutical candidates. The company operates a proprietary platform that integrates in silico and in vitro approaches to identify first-in-class molecules, addressing significant health challenges such as cancer, metabolic diseases, and multidrug-resistant infections. By digitizing life's natural diversity, AMPLY enhances the predictability and cost-effectiveness of discovering new therapeutics, enabling research entities to identify promising drug candidates based on their functional properties.

Cyted Health specializes in developing a digital diagnostic infrastructure aimed at the early detection of diseases, particularly cancer. By leveraging artificial intelligence and innovative biomarkers, Cyted's platform enhances clinical insights and facilitates improved patient outcomes. The company's mission is to transform diagnostic methodologies, focusing on prevention rather than treatment, thereby contributing to a healthcare landscape where diseases are identified and addressed at their earliest stages.

Holly Health is a digital health application designed to assist individuals in translating their health intentions into actionable daily practices for improved mental and physical wellbeing. Utilizing proprietary AI technology, the platform provides a personalized and empathetic experience that simulates the guidance of a human health coach. The application has received high ratings for its effectiveness in weight management, stress reduction, wellness, and sleep, earning a commendable score of 89% from ORCHA, a leading health app evaluation organization. Since its international launch in Summer 2021, Holly Health aims to support 5 million users by 2025 and is expanding its presence through partnerships with primary care practices in the UK, having established over 100 collaborations to date. The app features habit reminders, tailored health content, progress tracking, and motivational support, enabling users to prioritize and maintain healthier habits in their daily lives.

Holly Health is a digital health application designed to assist individuals in translating their health intentions into actionable daily practices for improved mental and physical wellbeing. Utilizing proprietary AI technology, the platform provides a personalized and empathetic experience that simulates the guidance of a human health coach. The application has received high ratings for its effectiveness in weight management, stress reduction, wellness, and sleep, earning a commendable score of 89% from ORCHA, a leading health app evaluation organization. Since its international launch in Summer 2021, Holly Health aims to support 5 million users by 2025 and is expanding its presence through partnerships with primary care practices in the UK, having established over 100 collaborations to date. The app features habit reminders, tailored health content, progress tracking, and motivational support, enabling users to prioritize and maintain healthier habits in their daily lives.

Nosh Technologies is a deep tech company focused on optimizing food management and reducing waste in households through innovative technology. The company develops algorithms and mobile applications designed to help users manage their food consumption more effectively. Its flagship product, an AI-powered smartphone app named Nosh, analyzes users' consumption and waste habits, providing insights and weekly analytics. This enables users to make informed decisions about their food usage, ultimately aiming to minimize waste and save money. Nosh Technologies serves clients globally, with a mission to eliminate food waste at home entirely.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Bendi is a data analytics company that specializes in enhancing global supply chain tracking and risk management. Its platform provides real-time traceability and risk monitoring, significantly reducing potential human rights, environmental, and governance risks associated with supply chains. By mapping millions of data points from diverse sources such as news articles, legal cases, and social media across multiple languages, Bendi equips businesses in various sectors—including fashion, textiles, retail, and advanced manufacturing—with actionable insights. This allows companies to streamline their operations, conduct audits more efficiently, and gain a comprehensive understanding of their supply chains.

Brainomix Limited is a medical technology company based in Oxford, United Kingdom, that specializes in developing imaging biomarkers and software solutions for neurological and cerebrovascular disorders. Founded in 2010 as a spin-out from the University of Oxford, Brainomix focuses on enhancing clinical decision-making through its AI-powered products. Its flagship offering, e-Stroke, comprises a suite of tools that provide real-time interpretation of brain scans, enabling healthcare professionals to make informed treatment decisions for stroke patients more efficiently. This includes e-ASPECTS, which automates the scoring of brain images to identify early stroke damage, and e-CTA, which standardizes the detection of large vessel occlusions. Additionally, e-Mismatch provides a multi-vendor post-processing solution for MRI and CT scans, enhancing the assessment of stroke damage. By leveraging advanced algorithms and large data analytics, Brainomix aims to improve patient outcomes by ensuring timely and appropriate treatment for stroke patients worldwide.

FruitCast specializes in AI-driven data analytics and yield forecasting for soft fruit growers. Utilizing non-destructive methods, it measures key metrics like fruit numbers, weight, and maturity of millions of berries daily. By integrating this data with other sources, FruitCast's platform predicts yields up to six weeks ahead, empowering businesses and farmers to optimize labor scheduling, enhance supply chain efficiency, and make informed decisions.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Watermarq is a company focused on developing decision-useful data to enhance water security through investment and collective action. By utilizing advanced technologies such as artificial intelligence and machine learning, Watermarq extracts high-resolution data from satellite imagery to provide operational insights into various environmental, social, and governance risks. Their outputs include accessible information on water availability, quality, value, and access, tailored for stakeholders in the public, private, and financial services sectors. This approach allows clients to make informed decisions based on observed data, facilitating better risk assessments and fostering sustainable water management practices.

DeepMirror is a developer of an artificial intelligence-based platform that enhances the drug discovery process for biopharma research and development teams. The company's technology predicts molecule properties and target affinity, allowing chemists to concentrate on the most promising drug candidates. By employing structured perception and feature fusion, DeepMirror provides robust three-dimensional analysis on devices with low power consumption, facilitating the simplification of complex data workflows. This approach not only saves researchers time but also reduces the need for extensive experimental trials, ultimately leading to the identification of more effective drugs.

Elaniti is a company focused on enhancing agricultural practices through advanced technologies in machine learning and DNA sequencing. It offers a proprietary predictive analytics service that connects soil biology to critical crop health metrics, such as yield, disease prevalence, and nutrient content. By providing insights into the complex biological makeup of soil, Elaniti empowers farmers and agronomists to make informed decisions that improve efficiency and reduce costs. The company's platform addresses the data gap in soil health and supports the transition to regenerative agriculture by optimizing the soil microbiome and fostering beneficial microbial activity. Elaniti aims to facilitate a sustainable approach to farming, contributing to environmental goals and promoting a data-driven pathway to Net-Zero agriculture.

Appella AI is revolutionizing retail e-commerce with hyper-personalized AI personal shoppers. By recreating the in-store shopping experience online, we help brands deliver tailored journeys that boost customer satisfaction, drive conversions, and foster loyalty. Leveraging cutting-edge recommender systems and large language models (LLMs), Appella’s AI provides conversational, intuitive shopping assistance. Beyond recommending products based on preferences and behavior, our solution offers trend insights and personalized marketing, ensuring every interaction reflects the brand’s unique identity. Launching on Shopify, Appella empowers e-commerce retailers to elevate their customer experience and unlock actionable insights to fuel growth.

AMPLY Discovery is a biotechnology company focused on drug discovery, utilizing machine learning and synthetic biology to explore vast biological datasets for novel drug and nutraceutical candidates. The company operates a proprietary platform that integrates in silico and in vitro approaches to identify first-in-class molecules, addressing significant health challenges such as cancer, metabolic diseases, and multidrug-resistant infections. By digitizing life's natural diversity, AMPLY enhances the predictability and cost-effectiveness of discovering new therapeutics, enabling research entities to identify promising drug candidates based on their functional properties.

Built AI is a developer of an advanced real estate investment analysis platform aimed at enhancing the efficiency and effectiveness of commercial property evaluations for real estate professionals. The platform leverages artificial intelligence and natural language processing to provide tools for screening and prospecting, investment analysis, and risk assessment. It also offers insights into historical deal pipelines and existing portfolios, as well as key local factors that influence investment decisions. By streamlining the analysis process, Built AI enables clients to gain a competitive edge in the challenging real estate market.

PhysioMedics is a healthcare technology company that specializes in online software solutions aimed at improving the management of musculoskeletal disorders. It has developed a self-assessment platform that offers data analytic insights and personalized self-help advice for individuals suffering from back pain. This platform enables patients to engage actively in their treatment by matching them with recommended treatment pathways. By facilitating better patient outcomes, PhysioMedics also helps organizations reduce costs associated with absenteeism and enhances the overall efficiency of managing musculoskeletal conditions.

DeepMirror is a developer of an artificial intelligence-based platform that enhances the drug discovery process for biopharma research and development teams. The company's technology predicts molecule properties and target affinity, allowing chemists to concentrate on the most promising drug candidates. By employing structured perception and feature fusion, DeepMirror provides robust three-dimensional analysis on devices with low power consumption, facilitating the simplification of complex data workflows. This approach not only saves researchers time but also reduces the need for extensive experimental trials, ultimately leading to the identification of more effective drugs.

Watermarq is a company focused on developing decision-useful data to enhance water security through investment and collective action. By utilizing advanced technologies such as artificial intelligence and machine learning, Watermarq extracts high-resolution data from satellite imagery to provide operational insights into various environmental, social, and governance risks. Their outputs include accessible information on water availability, quality, value, and access, tailored for stakeholders in the public, private, and financial services sectors. This approach allows clients to make informed decisions based on observed data, facilitating better risk assessments and fostering sustainable water management practices.

FourJaw Manufacturing Analytics is a provider of a machine-agnostic data analytics platform designed to enhance machining productivity through real-time insights into factory operations. The platform offers a comprehensive view of the shop floor, allowing users to monitor and record the status of each machine, thereby identifying and addressing unplanned downtime effectively. By delivering cloud-based machine monitoring, FourJaw enables small and medium-sized enterprise manufacturers to access critical manufacturing analytics, ultimately promoting improved productivity and operational efficiency.

BioStress Lab operates a proprietary stress management platform that leverages biometric data to accurately assess employee stress levels. This objective measurement enables businesses to enhance workplace wellbeing and productivity by providing personalized insights and strategies for stress mitigation.

Medwise.ai operates a customizable search platform designed to enhance clinical decision support for doctors. Leveraging natural language processing and artificial intelligence, the platform allows healthcare professionals to efficiently search for and organize medical knowledge. By utilizing real-world data, Medwise.ai provides valuable insights and intelligence to various stakeholders within the healthcare ecosystem. This innovative approach not only extends the capabilities of physicians but also aims to improve patient care and outcomes.

3AI is a machine learning company dedicated to building the world’s most advanced and usable AI for investment professionals, founded by an award-winning data science team of industry experts. 3AI is enhancing investor decision making with big data predictions and insights, enabling better judgement and results. ALBA is 3AI's self-learning equity prediction intelligence, producing reliably accurate global equity forecasts and insights. ALBA's top picks have consistently outperformed the S&P 500 since the 1980s.

Abtrace is a provider of AI-driven solutions designed to enhance medical expertise and improve patient care. The company focuses on developing clinical decision-making tools that transform the detection, monitoring, and treatment of chronic and long-term health conditions. By leveraging machine learning and big data techniques, Abtrace's software analyzes patient data to provide actionable insights for healthcare professionals. This technology helps general practitioners and healthcare assistants make informed decisions, automate disease monitoring, and recognize early clinical signs of new conditions. As a result, Abtrace aims to eliminate duplication, improve patient safety, reduce the misuse of antibiotics, and lower practice costs, ultimately leading to better treatment outcomes in real time.

Oxford Heartbeat is a developer of medical device software focused on improving the planning and execution of cardiovascular surgeries. The company offers a healthcare platform that provides surgeons with critical insights into real patient blood vessels, enabling them to visualize interactions between medical devices and arterial walls, as well as navigate through tissues and bones. This advanced simulation technology allows for unprecedented visibility during keyhole surgeries, facilitating rehearsal of surgical procedures and the selection of optimal approaches tailored to individual patients. By leveraging predictive computations, big data, and artificial intelligence, Oxford Heartbeat aims to enhance surgical preparation, ultimately leading to reduced complication rates, lower associated costs, and improved patient care. The company is actively conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

Glamorous AI is a developer of an advanced artificial intelligence-based drug discovery platform that focuses on low-data drug discovery. The platform utilizes AI to identify and optimize novel chemical scaffolds and screen extensive chemical libraries. By leveraging a large repository of pre-trained and customizable AI models, Glamorous AI addresses the challenges posed by sparse, noisy, and limited data. This innovative approach enables researchers to explore complex compounds and facilitates the discovery of first-in-class therapeutics, ultimately aiming to drive advancements in medicine and contribute to curing diseases.

Bendi is a data analytics company that specializes in enhancing global supply chain tracking and risk management. Its platform provides real-time traceability and risk monitoring, significantly reducing potential human rights, environmental, and governance risks associated with supply chains. By mapping millions of data points from diverse sources such as news articles, legal cases, and social media across multiple languages, Bendi equips businesses in various sectors—including fashion, textiles, retail, and advanced manufacturing—with actionable insights. This allows companies to streamline their operations, conduct audits more efficiently, and gain a comprehensive understanding of their supply chains.

NovaBleep is an innovative communications infrastructure layer specifically designed for hospitals. Various modular components are included to replace communication streams such as pagers, referral systems, fault reporting systems, concern escalation systems, ward chats etc. By streamlining and digitalising these essential communication processes, NovaBleep revolutionises the way hospitals operate. The flow of a patient from entering an ED to discharge/death represents the flow of data. Not all of this data is yet digitalised. Data will be aggregated using NovaBleep for use in Machine Learning to predict the trajectory of patients, and to potentially predict mortality.

IgniteData is a company focused on transforming clinical trials through innovative technology solutions. Its flagship product, Archer, is a cloud-based virtual research assistant that facilitates secure transmission of clinical data from electronic health records to electronic data capture systems. By automating patient data processes, IgniteData aims to enhance the efficiency of clinical research, enabling researchers to collect trial data more swiftly. This approach not only accelerates the development of crucial therapies but also improves the quality of studies while reducing the workload for research teams. Ultimately, IgniteData is dedicated to streamlining key clinical research processes to ensure that important medical advancements reach patients more quickly.

Etiq AI is a developer of AI-enabled testing software that assists companies in evaluating their data and models to identify errors, risks, and potential biases. The company's platform offers real-time analytics and decision-making capabilities, providing actionable recommendations for repairs and adjustments. By enabling organizations, particularly in the financial sector, to address bias issues and enhance the accuracy of their AI applications, Etiq AI helps drive improved business outcomes. The lightweight nature of its testing tool allows for efficient integration into existing workflows, making it a valuable resource for companies looking to ensure the reliability and fairness of their AI systems.

FinCrime Dynamics is a developer of advanced simulation and financial crime analytics tools aimed at enhancing the safety of the financial system through the effective use of artificial intelligence. The company specializes in creating enriched synthetic data that simulates the complexities of fraud and money laundering, allowing financial organizations to explore diverse threats through customized scenarios. This innovative approach enables businesses to establish benchmarks for financial crime analytics and address emerging challenges, such as those presented by online fraud during the COVID-19 pandemic. With a team of experts who have significantly contributed to the fields of synthetic data and financial crime analytics, FinCrime Dynamics is positioned at the forefront of these critical areas in the financial services sector.

Abtrace is a provider of AI-driven solutions designed to enhance medical expertise and improve patient care. The company focuses on developing clinical decision-making tools that transform the detection, monitoring, and treatment of chronic and long-term health conditions. By leveraging machine learning and big data techniques, Abtrace's software analyzes patient data to provide actionable insights for healthcare professionals. This technology helps general practitioners and healthcare assistants make informed decisions, automate disease monitoring, and recognize early clinical signs of new conditions. As a result, Abtrace aims to eliminate duplication, improve patient safety, reduce the misuse of antibiotics, and lower practice costs, ultimately leading to better treatment outcomes in real time.

Elixivity specializes in quantifying and benchmarking the impact of people-related factors on financial performance using artificial intelligence. The company develops a data management platform designed to provide insights for data-driven decision-making by identifying key patterns related to personnel within large datasets. This platform analyzes extensive data to correlate specific patterns, visualize various scenarios, and predict performance against chosen metrics. It enables enterprises to benchmark their inclusion and diversity status against competitors, sectors, and geographies.

Intelligent AI is a technology company that specializes in risk underwriting management, aiming to address the significant challenges of global business risk and business interruption claims. Founded on April 24, 2022, by Anthony Peake in Exeter, Devon, the company has developed a platform that leverages artificial intelligence, data science, satellite image analysis, and comprehensive risk data sets. This innovative platform provides global location intelligence, allowing insurers and corporations to gain a holistic view of risk across their commercial property portfolios. By enabling real-time measurement, prediction, and mitigation of property risks, Intelligent AI equips businesses with actionable insights to safeguard their operations and reduce the prevalence of underinsurance in property underwriting.

Albus Health is a startup originating from the University of Oxford, focusing on the development of an intelligent nocturnal monitoring platform for personalized home health monitoring. The platform enables passive, contactless, and objective tracking of various symptoms and environmental metrics. This innovative system is designed primarily for use in clinical trials by leading pharmaceutical companies, facilitating the monitoring of nocturnal symptoms and aiding in the prediction of respiratory emergencies. By providing detailed insights into patient conditions, Albus Health's technology supports pharmaceutical firms in optimizing their clinical studies while enhancing revenue potential.

Medwise.ai operates a customizable search platform designed to enhance clinical decision support for doctors. Leveraging natural language processing and artificial intelligence, the platform allows healthcare professionals to efficiently search for and organize medical knowledge. By utilizing real-world data, Medwise.ai provides valuable insights and intelligence to various stakeholders within the healthcare ecosystem. This innovative approach not only extends the capabilities of physicians but also aims to improve patient care and outcomes.

Game Doctor develops data-driven gamification technology. They offer services that include big data, mobile applications, health promotion, health marketing, public health, engagement, and behavior change.

Discova Health Ltd is a digital health company that offers an AI-powered mental health and resilience web application designed for corporations and the public sector. The platform provides personalized, evidence-based self-help interventions and action plans for prevalent mental health issues within minutes of sign-up. Unlike traditional solutions that merely address problems, Discova's approach focuses on predicting the most beneficial support pathways by analyzing data on user engagement, motivation, and behavior change. With over 1.9 million potential action plan combinations derived from its knowledge networks, the platform aims to deliver tailored support that can help prevent crises. Additionally, it empowers employees to take charge of their mental health through customized plans that incorporate professional, complementary, and peer interventions, promoting a supportive environment within organizations.

NovaBleep is an innovative communications infrastructure layer specifically designed for hospitals. Various modular components are included to replace communication streams such as pagers, referral systems, fault reporting systems, concern escalation systems, ward chats etc. By streamlining and digitalising these essential communication processes, NovaBleep revolutionises the way hospitals operate. The flow of a patient from entering an ED to discharge/death represents the flow of data. Not all of this data is yet digitalised. Data will be aggregated using NovaBleep for use in Machine Learning to predict the trajectory of patients, and to potentially predict mortality.

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Appt is making preventive healthcare effortless and accessible. Appt uses behavioural economics and data analytics to increase the uptake of preventive healthcare appointments - earning practices additional income and helping the delivery of nationally set prevention targets. Furthermore, through end-to-end automation of the call and recall process, Appt reduces cumbersome practice workload saving practice staff valuable time.

Cyted Health specializes in developing a digital diagnostic infrastructure aimed at the early detection of diseases, particularly cancer. By leveraging artificial intelligence and innovative biomarkers, Cyted's platform enhances clinical insights and facilitates improved patient outcomes. The company's mission is to transform diagnostic methodologies, focusing on prevention rather than treatment, thereby contributing to a healthcare landscape where diseases are identified and addressed at their earliest stages.

We help D2C brands grow the value of their customers faster by providing software, intelligence and expertise. Our Customer Data Intelligence Platform creates a genuine single point of truth, for every customer, by consolidating and deduplicating each data point. This enables brands to: • Quickly diagnose performance of marketing activity, accelerating the ability to test, learn and optimise. • Identify true VIPs and create strategies that build and track their engagement • Easy revenue forecast modelling, so brands know what it'll take to hit whatever revenue targets they're trying to achieve in seconds. • See how recent activity impacts predicted Customer Lifetime Value, so they can stop, continue or adjust to optimise acquisition. Our CRM personal data fields tool takes multiple customer data sources as inputs and uses customised logic to create rich metadata that can be used to personalise campaigns. This enables brands to: • To trigger, segment and personalise communications via their existing email marketing tools • Use multiple sources of customer data to increase personalisation, not just that which sits in a duplicated state within the e-commerce platform.

Healum is a developer of AI-powered software and applications aimed at enhancing self-management for individuals with long-term health conditions. The company’s technology enables users to effectively monitor and comprehend their physical and mental well-being. By leveraging data-driven insights and evidence-based behavioral interventions, Healum provides personalized care and support tailored to each patient's needs. This approach not only empowers patients in managing their chronic conditions but also aids healthcare professionals in delivering more effective care. Through its innovative solutions, Healum strives to improve health outcomes and promote greater patient engagement in their health management.

Albus Health is a startup originating from the University of Oxford, focusing on the development of an intelligent nocturnal monitoring platform for personalized home health monitoring. The platform enables passive, contactless, and objective tracking of various symptoms and environmental metrics. This innovative system is designed primarily for use in clinical trials by leading pharmaceutical companies, facilitating the monitoring of nocturnal symptoms and aiding in the prediction of respiratory emergencies. By providing detailed insights into patient conditions, Albus Health's technology supports pharmaceutical firms in optimizing their clinical studies while enhancing revenue potential.

Established, multi award-winning digital-health company, offering a world-class real-world evidence (RWE) data portfolio and analytics. Scientific rigor, gold-standard security and information governance - including GDPR and HIPAA - are combined with inclusive, patient-centric design in Vitaccess' pioneering and flexible digital platform. Patient- or clinician-reported data are anonymised then transferred to proprietary dashboards, offering real-time insights, and shortening publication times.

Oxford Heartbeat is a developer of medical device software focused on improving the planning and execution of cardiovascular surgeries. The company offers a healthcare platform that provides surgeons with critical insights into real patient blood vessels, enabling them to visualize interactions between medical devices and arterial walls, as well as navigate through tissues and bones. This advanced simulation technology allows for unprecedented visibility during keyhole surgeries, facilitating rehearsal of surgical procedures and the selection of optimal approaches tailored to individual patients. By leveraging predictive computations, big data, and artificial intelligence, Oxford Heartbeat aims to enhance surgical preparation, ultimately leading to reduced complication rates, lower associated costs, and improved patient care. The company is actively conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

MyWay Digital Health is an online self-management platform focused on enhancing the lives of individuals with long-term health conditions, particularly diabetes. The platform offers users access to their health records, personalized advice, and educational resources aimed at empowering them to manage their conditions effectively. Additionally, it provides clinical and management tools that support population analytics and clinician decision-making. Through its data-driven technology solutions, MyWay Digital Health seeks to improve health outcomes for users worldwide by facilitating better management of their health conditions.

Albus Health is a startup originating from the University of Oxford, focusing on the development of an intelligent nocturnal monitoring platform for personalized home health monitoring. The platform enables passive, contactless, and objective tracking of various symptoms and environmental metrics. This innovative system is designed primarily for use in clinical trials by leading pharmaceutical companies, facilitating the monitoring of nocturnal symptoms and aiding in the prediction of respiratory emergencies. By providing detailed insights into patient conditions, Albus Health's technology supports pharmaceutical firms in optimizing their clinical studies while enhancing revenue potential.

Circadian Capital is a provider of cloud services focused on simplifying data handling for businesses. The company specializes in creating bespoke solutions that utilize web-based cloud technology to manage and process data efficiently. By enabling users to handle tasks such as pricing, workflows, and case management, Circadian Capital allows organizations to outsource back office functions effectively. Additionally, the company employs behavioral analysis to detect fraud and recognize customers, enhancing security and customer experience. Through its innovative approach, Circadian Capital aims to make data management fast, affordable, and robust for its clients.

We help D2C brands grow the value of their customers faster by providing software, intelligence and expertise. Our Customer Data Intelligence Platform creates a genuine single point of truth, for every customer, by consolidating and deduplicating each data point. This enables brands to: • Quickly diagnose performance of marketing activity, accelerating the ability to test, learn and optimise. • Identify true VIPs and create strategies that build and track their engagement • Easy revenue forecast modelling, so brands know what it'll take to hit whatever revenue targets they're trying to achieve in seconds. • See how recent activity impacts predicted Customer Lifetime Value, so they can stop, continue or adjust to optimise acquisition. Our CRM personal data fields tool takes multiple customer data sources as inputs and uses customised logic to create rich metadata that can be used to personalise campaigns. This enables brands to: • To trigger, segment and personalise communications via their existing email marketing tools • Use multiple sources of customer data to increase personalisation, not just that which sits in a duplicated state within the e-commerce platform.

Vivacity Labs Ltd. is a London-based company that specializes in hyper-local data solutions for smart cities and intelligent transport systems. Founded in 2015, it focuses on enhancing urban mobility by providing services such as car parking sensing, bus occupancy monitoring, and comprehensive traffic analysis. The company employs advanced technologies, including machine learning and artificial intelligence, to install thousands of sensors across the UK, including in Milton Keynes, the UK's first transport-focused smart city. These sensors collect unprecedented data from video feeds, enabling deep insights into transport operations and predictive management. Additionally, Vivacity Labs offers video analytics services that extract meaningful information from visual data and provides detailed transport metrics, such as speed, counts, and heat maps, through API access and online interfaces. By empowering transport managers with enhanced insights, Vivacity Labs aims to reduce congestion and improve road safety.

Oxford Heartbeat is a developer of medical device software focused on improving the planning and execution of cardiovascular surgeries. The company offers a healthcare platform that provides surgeons with critical insights into real patient blood vessels, enabling them to visualize interactions between medical devices and arterial walls, as well as navigate through tissues and bones. This advanced simulation technology allows for unprecedented visibility during keyhole surgeries, facilitating rehearsal of surgical procedures and the selection of optimal approaches tailored to individual patients. By leveraging predictive computations, big data, and artificial intelligence, Oxford Heartbeat aims to enhance surgical preparation, ultimately leading to reduced complication rates, lower associated costs, and improved patient care. The company is actively conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

Sensing Feeling Limited is a London-based company that specializes in developing Internet of Things (IoT) human behavior sensing products tailored for business applications. Founded in 2013, the company leverages advanced technologies such as computer vision and machine learning to provide reliable and effective measurement of aggregated human behavior within physical spaces. Its innovative software enables real-time monitoring of behavioral indices, allowing organizations to enhance safety, understand risks, and improve customer experiences. By utilizing deep learning and artificial intelligence, Sensing Feeling's solutions are designed to accurately sense and analyze the behavior of individuals and groups, as well as vehicles and other assets, thereby supporting effective management in safety-critical environments.

Outcomes Based Healthcare is a company dedicated to enhancing the healthcare system through outcome-based methodologies. It focuses on co-creating healthcare outcomes alongside patients, employing both academic and technical rigor in measuring and contracting for these outcomes. The company develops technology products that assist commissioners and health providers in tracking and measuring health outcomes for specific population segments. By integrating health and non-health datasets and utilizing big data analytics with machine learning techniques, Outcomes Based Healthcare aims to predict health outcomes effectively. Additionally, it creates smartphone applications to assess Patient Reported Outcomes. The team comprises professionals with diverse expertise in medicine, business, economics, computer science, and web technology, all committed to designing patient-centered care and empowering the health system through innovative technological solutions.

Big Data Partnership is a consulting firm that assists organizations across various industries in becoming data-driven through the adoption of advanced data science and big data technologies. As companies generate data at unprecedented rates, particularly unstructured data from sources such as social networks and mobile content, Big Data Partnership aims to help clients harness this complexity for competitive advantage. The firm offers a range of services, including big data engineering, data science, and certified training and support, with a focus on technologies like the Apache Hadoop ecosystem, Apache Spark, and Apache Cassandra. By enabling organizations to effectively capture, store, and analyze large datasets, Big Data Partnership strives to transform data into a valuable asset, driving new revenue streams and enhancing operational efficiency. Their team consists of certified industry experts who provide tailored, cost-effective solutions while reducing risks by training client staff in necessary skills.

Perspectum is a global medical technology company dedicated to enhancing patient care for individuals with liver disease, diabetes, and cancer. The company specializes in precision medicine, utilizing advanced imaging and genetics to provide clinicians with quantitative health assessments. This approach enables early detection, accurate diagnosis, and targeted treatment of complex health issues. Perspectum's team comprises physicians, biomedical scientists, engineers, and technologists who work together to manage these conditions at scale, empowering both patients and healthcare providers.

Warwick Analytics specializes in advanced predictive analytics and process automation, offering innovative solutions to convert raw data into structured formats. Their flagship product, PrediCX, utilizes proprietary technology known as Optimised Learning to automatically classify text-heavy data through machine learning. This approach emphasizes labeling concepts rather than relying on predefined rules, significantly reducing the need for human intervention while maximizing accuracy. PrediCX is versatile, providing enhanced insights into verbatim text data, facilitating Robotic Process Automation, and conducting sentiment analysis for consumer feedback. Overall, Warwick Analytics aims to lower the cost barriers associated with predictive analytics, helping customers improve quality, throughput, and customer behavior prediction.